🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ab#20 ASCO #GU25 by #DavidFisher👉bit.ly/42JWtNo👉Meta-analysis of key trials in mHSPC #prostatecancer👉ARPI benefits all, higher benefit in younger age, higher BMI, low-volume disease 👇#JayneTierney OncoAlert UroToday.com PCF Science SWOG Cancer Research Network

Update on EV-302 with 2.5 years mFU re inforces EV+P as the SOV for 1 st line la/mUC🦀🏅🥂 @asco #GU2025

'Unfavorable Histology’ classification aims to reduce unnecessary treatment #JournalClub. Matt Cooperberg hosts a discussion about redefining adverse pathology. This simplified "favorable vs. unfavorable" histology model, focusing on cribriform patterns, outperforms Gleason grades in

⏩ ASCO #GU25 Day 3⃣ starts! Laurence Albiges 👑 is on the stage ! ❌Adding Cabozantinib to Nivolumab + Ipilimumab did not improve OS in 1L intermediate/poor-risk aRCC, with higher AEs rates! The ASCO Post ASCO TECAG OncoAlert Sumanta K. Pal, MD, FASCO Conquer Cancer, the ASCO Foundation Michael Serzan, MD Renee Maria Saliby

🗣️Kidney Cancer Oral Abstracts #GU25 👉Abs439: Dr Marc Motzer presenting Final Results from #CM9ER ♦️Cabo + Nivo (CN) ♦️Sunitinib (S) Median FU 67.6mo ITT ✅ mOS: CN 46.5mo vs S 35.5mo (0.79, 0.65–0.96) ✅ mPFS: CN 16.4mo vs S 8.3mo (0.58, 0.49–0.70) ✅ ORR : CN 55.7% vs S 27.4%

A simple summary with the most updated results from the phase 3 trials with available IO-combos in mRCC after #GU25. OncoAlert UroToday.com GU Oncology Now UroFocus Società Italiana di Urologia SIUrO

Great session on ADCs (anti-drug conjugates) for advanced/metastatic bladder cancer at #GU25 Great panel with Maria Jiang (Princess Margaret Cancer Centre), Dr Meric-Bernstam (MD Anderson Cancer Center) and good friends Daniel Castellano (GU Unit Hospital12O) and Dr Terry Friedlander (UCSF Helen Diller Family Comprehensive Cancer Ctr)

#GU25 highlights #CommunityOnc: 1. Radical ✂️ vs. XRT high risk PCa 2. #TALAPRO2: PARPi in M1 CRPC 3. #EnzaP: ARPi + LuPSMA in M1 CRPC 4. #NIAGARA update: Resectable MIBC 5. #EV302 update: Metastatic #BladderCancer 6. #CM9ER update: 1L mRCC #OncTwitter #gism ASCO 1/7

Is there a role of PSMA-PET in focal therapy planning and follow-up? A Review out on Prostate Cancer nature.com/articles/s4139… Focal therapy (FT) is emerging as a potential alternative to radical treatments for localized #ProstateCancer , though it is not yet standardized, and

🎉 ¡Lanzamos el Curso de Residentes CAU-SCHU 2025! 🎉 Una propuesta educativa IMPERDIBLE con profesores de altísimo nivel para seguir garantizando la excelencia académica. Link de Inscripción: educacion.caunet.org Sociedad Chilena de Urología Oficina Residentes CAU Nahuel Paesano Luis Ebel siupurol

Thrilled and honored to represent South Central Section of the AUA and Mexico at #AUA25 I have been invited to participate in the 2025 Global Residents Leadership Retreat and I will also be competing in the Resident Quiz Bowl. Very grateful for the opportunities! Amer. Urol. Assn. Urología Gea

The 12th Annual AUA Residents Bowl is taking place at #AUA25! Check out the schedule and be sure to cheer your Section to victory! Learn more here! ➡️ bit.ly/4kJodIo

Global Resident’s Leadership Retreat with Dave Penson : conversing with the future of urology. Top ideas: value mentorship, self awareness, and relationships! Amer. Urol. Assn. #AUA25

Awesome start at #AUA25 with the Global Residents Leadership Retreat! Big lessons learned and new friendships made! Thanks South Central Section of the AUA & Amer. Urol. Assn.

South Central Section defeats The Northeastern Section to move on to tomorrow’s Residents Bowl Finals! Stop by the AUA Residents Pavilion tomorrow at 1 p.m. to catch the finals and see who takes home the trophy! 🏆 #AUA25 #Urology

Great participation, Marco Ascencio , winner of the resident’s bowl, with South Central Section of the AUA

#AUA25 Residents bowl winners! South Central Section of the AUA Urología Gea

I represented South Central Section and Mexico in the Residents Bowl at #AUA25 Thanks to an amazing team effort we won! Very grateful to everyone that have supported me throughout my training as a urologist! Amer. Urol. Assn. South Central Section of the AUA SMU México Residentes SMU 🇲🇽 Urología Gea

Great case, Valdivia-Galdakao position, single & only one punction of Marco Ascencio total SF, great job Marco Ascencio

Longer follow up for Enfortumab Vedotin & Pembro in urothelial cancer Annals of Oncology shows mOS at nearly 3 yrs (34 mnths) with 50% of responses (68%) continuing at 2 years! Experience in tox management is important. Duration of therapy uncertain in CR gbr01.safelinks.protection.outlook.com/?url=https%3A%…